Background illustration for clinical trials search

Paid Clinical Trials Iowa

Discover 667 paid clinical trials in Iowa. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

New Non-invasive Modalities for Assessing Retinal Structure and Function

for
Ischemic Optic Neuropathy, Branch Retinal Artery Occlusion,
Location: Iowa City IA
Sponsor: Randy Kardon

Sex: All

Age: 18 - 70+

Code: NCT03475173

Recruiting

Patisiran-Lipid Nanoparticle (LNP) Pregnancy Surveillance Program

for
Hereditary Transthyretin-mediated (hATTR) Amyloidosis,
Location: Iowa City IA
Sponsor: Alnylam Pharmaceuticals

Sex: Female

Age: 0+

Code: NCT05040373

Recruiting

CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes

for
End-Stage Kidney Disease, End-Stage Renal Disease
Location: Philadelphia PA, Durham NC, Pittsburgh PA,
Sponsor: VA Office of Research and Development

Sex: All

Age: 18+

Code: NCT05931276

Phase 3, Recruiting

Prenatal Aspirin and Postpartum Vascular Function

for
Preeclampsia, Microvascular Function
Location: Iowa City IA
Sponsor: Anna Stanhewicz, PhD

Sex: Female

Age: 18 - 50

Code: NCT05653973

Early Phase 1, Recruiting

Otoferlin Gene-mediated Hearing Loss Natural History Study

for
Sensorineural Hearing Loss, Bilateral
Location: Philadelphia PA, Cincinnati OH, Nashville TN,
Sponsor: Akouos, Inc.

Sex: All

Age: 0 - 44

Code: NCT05572073

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Impact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathy

for
Peripartum Cardiomyopathy, Postpartum
Location: Boston MA, Providence RI, Hartford CT, New Haven CT,
Sponsor: Dennis M. McNamara, MD, MS

Sex: Female

Age: 18+

Code: NCT05180773

Recruiting

Temozolomide and Atezolizumab for Subsequent Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer

for
Extensive Stage Lung Small Cell Carcinoma,
Location: Columbus OH, Indianapolis IN, Chicago IL, Madison WI,
Sponsor: Dwight Owen

Sex: All

Age: 18+

Code: NCT04919382

Phase 2, Recruiting

Rigorous Evaluation of the READY to Stand Curriculum to Prevent the Commercial Sexual Exploitation of Children

for
Sex Trafficking, Sex Crimes, Commercial Sex, Sexual Violence,
Location: Des Moines IA
Sponsor: University of Michigan

Sex: All

Age: 13 - 19

Code: NCT06587529

Recruiting

GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study

for
Stroke, PFO - Patent Foramen Ovale
Location: Boston MA, New Haven CT, Allentown PA,
Sponsor: W.L.Gore & Associates

Sex: All

Age: 18 - 70

Code: NCT03821129

Recruiting

Safety and Efficacy of Tideglusib in Congenital or Childhood Onset Myotonic Dystrophy

for
Congenital Myotonic Dystrophy
Location: Ottawa, Rochester NY, Pittsburgh PA, Chicago IL,
Sponsor: AMO Pharma Limited

Sex: All

Age: 6 - 45

Code: NCT05004129

Phase 2, Phase 3, Recruiting

Quantitative MRI Assessment of Breast Cancer Therapy Response

for
Breast Cancer
Location: Royal Oak MI, Iowa City IA, Seattle WA
Sponsor: Corewell Health East

Sex: All

Age: 18+

Code: NCT05704062

Recruiting

Limited-duration Teclistamab

for
Myeloma Multiple
Location: New York NY, Philadelphia PA, Iowa City IA,
Sponsor: Abramson Cancer Center at Penn Medicine

Sex: All

Age: 18+

Code: NCT05932680

Phase 2, Recruiting

VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]

for
Advanced Melanoma
Location: Providence RI, Lebanon NH, Lake Success NY,
Sponsor: Replimune, Inc.

Sex: All

Age: 12+

Code: NCT06264180

Phase 3, Recruiting

Dichoptic Treatment for Amblyopia in Children 8 to 12 Years of Age

for
Amblyopia
Location: Boston MA, New York NY, Philadelphia PA, Norfolk VA,
Sponsor: Jaeb Center for Health Research

Sex: All

Age: 8 - 12

Code: NCT06524882

Phase 3, Recruiting

Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for Prevention of VA Loss Due to Radiation Retinopathy

for
Radiation Retinopathy, Visual Impairment
Location: Boston MA, Manchester CT, Philadelphia PA, Durham NC,
Sponsor: Jaeb Center for Health Research

Sex: All

Age: 18+

Code: NCT05844982

Phase 3, Recruiting

A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

for
Carcinoma, Non-Small-Cell Lung
Location: Boston MA, Shirley NY, New Haven CT, Lebanon NH,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06667076

Phase 2, Recruiting

Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemotherapy Treatment for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside the Lung

for
Advanced Extrapulmonary Neuroendocrine Carcinoma,
Location: Peabody MA, Burlington MA, Westerly RI, Waterford CT,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05058651

Phase 2, Phase 3, Recruiting

Post-Filter Hematocrit

for
Continuous Renal Replacement Therapy, Renal Failure,
Location: Iowa City IA
Sponsor: Gwyndolyn M. Radford

Sex: All

Age: 18+

Code: NCT07293936

Recruiting

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

for
Overweight, Prediabetic State, Prehypertension,
Location: Boston MA, Waterbury CT, Hartsdale NY,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07794579

Phase 3, Recruiting

A Study to Assess the Safety, Tolerability, and Immunogenicity of 3 Lots of a Multivalent Pneumococcal Conjugate Vaccine Administered to Adults

for
Pneumococcal Disease
Location: Milford CT, Somers Point NJ, Philadelphia PA,
Sponsor: Pfizer

Sex: All

Age: 18 - 49

Code: NCT07794748

Phase 3, Recruiting

Popular cities in Iowa

Offering a distinguished healthcare infrastructure and top class research institutions, Iowa has emerged as a significant base for a wide range of clinical trials. Major institutions such as the University of Iowa Hospitals and Clinics and the Holden Comprehensive Cancer Center are at the forefront of these studies, driving advancements in fields like oncology, cardiovascular research, and more. Iowa’s commitment to medical innovation and its growing network of research centers make it a developing hub in cutting-edge clinical trials.

Why choose Iowa for clinical trials?

Iowa offers distinct advantages for those participating in clinical trials. The state's distinct population, combined with its strong agricultural and rural communities, provides a diverse range of participants that enhances the accuracy and applicability of research findings. Iowa is also recognized for its innovative research environment and its cutting-edge medical advancements, driven by leading institutions such as the University of Iowa.

By choosing to participate in a clinical trial in Iowa, participants contribute to critical medical research while benefiting from a well-established and supportive clinical research infrastructure that promotes breakthroughs in patient care and treatment.

Common conditions studied in Iowa

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Iowa